Last updated on 28 May 2022
Owner Info
Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge MA 02142, UNITED STATES OF AMERICA
Serial Number
2242228 filed on 19 Oct 2021
Correspondent
Timothy H. Hiebert Womble Bond Dickinson (US) LLP
470 Atlantic Ave.,
Boston MA 02210-2228,
UNITED STATES OF AMERICA
2242228
19 Oct 2021
19 Oct 2031
FIGURATIVE
Status Date | Action Taken |
---|---|
28th May 2022 | International Registration in Australia Protected correspondence sent |
27th May 2022 | IP Right Registration Published |
27th May 2022 | Status change to Registered/Protected |
20th Mar 2022 | Application Accepted correspondence sent |
20th Mar 2022 | IP Right has been Examined |
20th Mar 2022 | IP Right Acceptance Published |
17th Mar 2022 | Status change to Accepted |
13th Jan 2022 | Awaiting examination |
13th Jan 2022 | Word and image indexing completed |
13th Jan 2022 | IP Right Filed Published |